nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Fluorouracil—pancreatic cancer	0.12	0.162	CbGbCtD
Gadoxetate—ABCC4—Fluorouracil—pancreatic cancer	0.0919	0.124	CbGbCtD
Gadoxetate—SLCO1B3—Docetaxel—pancreatic cancer	0.0816	0.11	CbGbCtD
Gadoxetate—ABCC2—Tamoxifen—pancreatic cancer	0.0742	0.0999	CbGbCtD
Gadoxetate—ABCC4—Sunitinib—pancreatic cancer	0.0699	0.0941	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—pancreatic cancer	0.0685	0.0922	CbGbCtD
Gadoxetate—SLCO1B1—Irinotecan—pancreatic cancer	0.0648	0.0873	CbGbCtD
Gadoxetate—ABCC2—Irinotecan—pancreatic cancer	0.057	0.0767	CbGbCtD
Gadoxetate—ABCC2—Docetaxel—pancreatic cancer	0.0418	0.0562	CbGbCtD
Gadoxetate—ABCC2—Sunitinib—pancreatic cancer	0.0416	0.056	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—pancreatic cancer	0.0311	0.0419	CbGbCtD
Gadoxetate—ABCC3—bile duct—pancreatic cancer	0.0189	0.332	CbGeAlD
Gadoxetate—ABCC2—bile duct—pancreatic cancer	0.0151	0.265	CbGeAlD
Gadoxetate—ABCC2—bile—pancreatic cancer	0.0116	0.204	CbGeAlD
Gadoxetate—ABCC3—gall bladder—pancreatic cancer	0.00402	0.0707	CbGeAlD
Gadoxetate—SLCO1B1—digestive system—pancreatic cancer	0.00167	0.0293	CbGeAlD
Gadoxetate—ABCC3—digestive system—pancreatic cancer	0.00158	0.0278	CbGeAlD
Gadoxetate—ABCC4—pancreas—pancreatic cancer	0.00153	0.0269	CbGeAlD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00147	0.0766	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.00146	0.0759	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00139	0.0721	CbGpPWpGaD
Gadoxetate—ABCC4—digestive system—pancreatic cancer	0.00131	0.023	CbGeAlD
Gadoxetate—ABCC2—digestive system—pancreatic cancer	0.00127	0.0222	CbGeAlD
Gadoxetate—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.000981	0.051	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—LY6E—pancreatic cancer	0.00084	0.0437	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00074	0.0385	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000696	0.0362	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—FGF13—pancreatic cancer	0.000647	0.0336	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—FGF13—pancreatic cancer	0.000609	0.0316	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000587	0.0305	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000552	0.0287	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—FGF13—pancreatic cancer	0.000513	0.0267	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000334	0.0174	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000314	0.0163	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000313	0.0163	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000231	0.012	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000211	0.0109	CbGpPWpGaD
Gadoxetate—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.0002	0.00111	CcSEcCtD
Gadoxetate—Hypotension—Fluorouracil—pancreatic cancer	0.0002	0.0011	CcSEcCtD
Gadoxetate—Hypersensitivity—Sunitinib—pancreatic cancer	0.0002	0.0011	CcSEcCtD
Gadoxetate—Rash—Tamoxifen—pancreatic cancer	0.0002	0.0011	CcSEcCtD
Gadoxetate—Dermatitis—Tamoxifen—pancreatic cancer	0.0002	0.0011	CcSEcCtD
Gadoxetate—Vomiting—Erlotinib—pancreatic cancer	0.000199	0.0011	CcSEcCtD
Gadoxetate—Dyspnoea—Irinotecan—pancreatic cancer	0.000199	0.0011	CcSEcCtD
Gadoxetate—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000199	0.0011	CcSEcCtD
Gadoxetate—Headache—Tamoxifen—pancreatic cancer	0.000199	0.0011	CcSEcCtD
Gadoxetate—Rash—Erlotinib—pancreatic cancer	0.000198	0.00109	CcSEcCtD
Gadoxetate—Dermatitis—Erlotinib—pancreatic cancer	0.000197	0.00109	CcSEcCtD
Gadoxetate—Angiopathy—Docetaxel—pancreatic cancer	0.000197	0.00109	CcSEcCtD
Gadoxetate—Dehydration—Epirubicin—pancreatic cancer	0.000197	0.00109	CcSEcCtD
Gadoxetate—Immune system disorder—Docetaxel—pancreatic cancer	0.000196	0.00108	CcSEcCtD
Gadoxetate—Headache—Erlotinib—pancreatic cancer	0.000196	0.00108	CcSEcCtD
Gadoxetate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000196	0.00108	CcSEcCtD
Gadoxetate—Paraesthesia—Gemcitabine—pancreatic cancer	0.000196	0.00108	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000195	0.0102	CbGpPWpGaD
Gadoxetate—Chills—Docetaxel—pancreatic cancer	0.000195	0.00108	CcSEcCtD
Gadoxetate—Asthenia—Sunitinib—pancreatic cancer	0.000195	0.00107	CcSEcCtD
Gadoxetate—Decreased appetite—Irinotecan—pancreatic cancer	0.000194	0.00107	CcSEcCtD
Gadoxetate—Arrhythmia—Docetaxel—pancreatic cancer	0.000194	0.00107	CcSEcCtD
Gadoxetate—Dyspnoea—Gemcitabine—pancreatic cancer	0.000194	0.00107	CcSEcCtD
Gadoxetate—Hypokalaemia—Epirubicin—pancreatic cancer	0.000193	0.00107	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000193	0.00107	CcSEcCtD
Gadoxetate—Fatigue—Irinotecan—pancreatic cancer	0.000193	0.00106	CcSEcCtD
Gadoxetate—Paraesthesia—Fluorouracil—pancreatic cancer	0.000192	0.00106	CcSEcCtD
Gadoxetate—Pruritus—Sunitinib—pancreatic cancer	0.000192	0.00106	CcSEcCtD
Gadoxetate—Constipation—Irinotecan—pancreatic cancer	0.000191	0.00106	CcSEcCtD
Gadoxetate—Dyspnoea—Fluorouracil—pancreatic cancer	0.000191	0.00105	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—pancreatic cancer	0.000189	0.00105	CcSEcCtD
Gadoxetate—Decreased appetite—Gemcitabine—pancreatic cancer	0.000189	0.00104	CcSEcCtD
Gadoxetate—Nausea—Tamoxifen—pancreatic cancer	0.000188	0.00104	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000188	0.00104	CcSEcCtD
Gadoxetate—Fatigue—Gemcitabine—pancreatic cancer	0.000188	0.00104	CcSEcCtD
Gadoxetate—Constipation—Gemcitabine—pancreatic cancer	0.000186	0.00103	CcSEcCtD
Gadoxetate—Nausea—Erlotinib—pancreatic cancer	0.000186	0.00103	CcSEcCtD
Gadoxetate—Decreased appetite—Fluorouracil—pancreatic cancer	0.000186	0.00103	CcSEcCtD
Gadoxetate—Diarrhoea—Sunitinib—pancreatic cancer	0.000186	0.00102	CcSEcCtD
Gadoxetate—Dysgeusia—Docetaxel—pancreatic cancer	0.000185	0.00102	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000185	0.00102	CcSEcCtD
Gadoxetate—Abdominal distension—Epirubicin—pancreatic cancer	0.000185	0.00102	CcSEcCtD
Gadoxetate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000184	0.00102	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000184	0.00101	CcSEcCtD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000183	0.00953	CbGpPWpGaD
Gadoxetate—Dysphagia—Epirubicin—pancreatic cancer	0.000183	0.00101	CcSEcCtD
Gadoxetate—Back pain—Docetaxel—pancreatic cancer	0.000183	0.00101	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000183	0.00101	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—pancreatic cancer	0.000182	0.00101	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—NFE2L2—pancreatic cancer	0.000182	0.00944	CbGpPWpGaD
Gadoxetate—Dizziness—Sunitinib—pancreatic cancer	0.000179	0.000991	CcSEcCtD
Gadoxetate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000179	0.00099	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000179	0.000986	CcSEcCtD
Gadoxetate—Abdominal pain—Irinotecan—pancreatic cancer	0.000177	0.000975	CcSEcCtD
Gadoxetate—Body temperature increased—Irinotecan—pancreatic cancer	0.000177	0.000975	CcSEcCtD
Gadoxetate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000176	0.000974	CcSEcCtD
Gadoxetate—Bronchitis—Epirubicin—pancreatic cancer	0.000176	0.000973	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000176	0.00916	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFA—pancreatic cancer	0.000173	0.009	CbGpPWpGaD
Gadoxetate—Vomiting—Sunitinib—pancreatic cancer	0.000173	0.000952	CcSEcCtD
Gadoxetate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000172	0.00095	CcSEcCtD
Gadoxetate—Rash—Sunitinib—pancreatic cancer	0.000171	0.000944	CcSEcCtD
Gadoxetate—Dermatitis—Sunitinib—pancreatic cancer	0.000171	0.000944	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—pancreatic cancer	0.000171	0.000942	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—NFE2L2—pancreatic cancer	0.000171	0.00887	CbGpPWpGaD
Gadoxetate—Urticaria—Fluorouracil—pancreatic cancer	0.00017	0.000939	CcSEcCtD
Gadoxetate—Headache—Sunitinib—pancreatic cancer	0.00017	0.000938	CcSEcCtD
Gadoxetate—Syncope—Docetaxel—pancreatic cancer	0.00017	0.000937	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—pancreatic cancer	0.00017	0.000936	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC2A2—pancreatic cancer	0.00017	0.00881	CbGpPWpGaD
Gadoxetate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000169	0.000934	CcSEcCtD
Gadoxetate—Palpitations—Docetaxel—pancreatic cancer	0.000167	0.000924	CcSEcCtD
Gadoxetate—Loss of consciousness—Docetaxel—pancreatic cancer	0.000166	0.000919	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000166	0.00861	CbGpPWpGaD
Gadoxetate—Cough—Docetaxel—pancreatic cancer	0.000165	0.000912	CcSEcCtD
Gadoxetate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000165	0.000909	CcSEcCtD
Gadoxetate—Convulsion—Docetaxel—pancreatic cancer	0.000164	0.000906	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—pancreatic cancer	0.000163	0.0009	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—TGFA—pancreatic cancer	0.000163	0.00846	CbGpPWpGaD
Gadoxetate—Chest pain—Docetaxel—pancreatic cancer	0.000161	0.00089	CcSEcCtD
Gadoxetate—Nausea—Sunitinib—pancreatic cancer	0.000161	0.00089	CcSEcCtD
Gadoxetate—Renal failure—Epirubicin—pancreatic cancer	0.000161	0.000887	CcSEcCtD
Gadoxetate—Asthenia—Irinotecan—pancreatic cancer	0.00016	0.000885	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—SHH—pancreatic cancer	0.00016	0.00833	CbGpPWpGaD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00016	0.000884	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SLC2A2—pancreatic cancer	0.000159	0.00828	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000159	0.00828	CbGpPWpGaD
Gadoxetate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000159	0.000877	CcSEcCtD
Gadoxetate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000158	0.000871	CcSEcCtD
Gadoxetate—Dry mouth—Docetaxel—pancreatic cancer	0.000158	0.00087	CcSEcCtD
Gadoxetate—Asthenia—Gemcitabine—pancreatic cancer	0.000156	0.000862	CcSEcCtD
Gadoxetate—Oedema—Docetaxel—pancreatic cancer	0.000155	0.000853	CcSEcCtD
Gadoxetate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000155	0.000853	CcSEcCtD
Gadoxetate—Pruritus—Gemcitabine—pancreatic cancer	0.000154	0.00085	CcSEcCtD
Gadoxetate—Infection—Docetaxel—pancreatic cancer	0.000154	0.000847	CcSEcCtD
Gadoxetate—Diarrhoea—Irinotecan—pancreatic cancer	0.000153	0.000844	CcSEcCtD
Gadoxetate—Shock—Docetaxel—pancreatic cancer	0.000152	0.000839	CcSEcCtD
Gadoxetate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000152	0.000836	CcSEcCtD
Gadoxetate—Pruritus—Fluorouracil—pancreatic cancer	0.000151	0.000836	CcSEcCtD
Gadoxetate—Tachycardia—Docetaxel—pancreatic cancer	0.000151	0.000832	CcSEcCtD
Gadoxetate—Skin disorder—Docetaxel—pancreatic cancer	0.00015	0.000828	CcSEcCtD
Gadoxetate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000149	0.000822	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—pancreatic cancer	0.000149	0.00082	CcSEcCtD
Gadoxetate—Dizziness—Irinotecan—pancreatic cancer	0.000148	0.000816	CcSEcCtD
Gadoxetate—Anorexia—Docetaxel—pancreatic cancer	0.000147	0.000813	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—pancreatic cancer	0.000147	0.000812	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000147	0.000811	CcSEcCtD
Gadoxetate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000146	0.000809	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000146	0.000806	CcSEcCtD
Gadoxetate—Hypotension—Docetaxel—pancreatic cancer	0.000144	0.000797	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000144	0.000796	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—NFE2L2—pancreatic cancer	0.000144	0.00748	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000144	0.00747	CbGpPWpGaD
Gadoxetate—Vomiting—Irinotecan—pancreatic cancer	0.000142	0.000785	CcSEcCtD
Gadoxetate—Dizziness—Fluorouracil—pancreatic cancer	0.000142	0.000781	CcSEcCtD
Gadoxetate—Rash—Irinotecan—pancreatic cancer	0.000141	0.000778	CcSEcCtD
Gadoxetate—Dermatitis—Irinotecan—pancreatic cancer	0.000141	0.000777	CcSEcCtD
Gadoxetate—Headache—Irinotecan—pancreatic cancer	0.00014	0.000773	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00014	0.00726	CbGpPWpGaD
Gadoxetate—Paraesthesia—Docetaxel—pancreatic cancer	0.000139	0.000766	CcSEcCtD
Gadoxetate—Vomiting—Gemcitabine—pancreatic cancer	0.000138	0.000764	CcSEcCtD
Gadoxetate—Dyspnoea—Docetaxel—pancreatic cancer	0.000138	0.00076	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—TGFA—pancreatic cancer	0.000137	0.00714	CbGpPWpGaD
Gadoxetate—Rash—Gemcitabine—pancreatic cancer	0.000137	0.000758	CcSEcCtD
Gadoxetate—Dermatitis—Gemcitabine—pancreatic cancer	0.000137	0.000757	CcSEcCtD
Gadoxetate—Headache—Gemcitabine—pancreatic cancer	0.000136	0.000753	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—pancreatic cancer	0.000136	0.000752	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000136	0.000752	CcSEcCtD
Gadoxetate—Vomiting—Fluorouracil—pancreatic cancer	0.000136	0.000751	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—pancreatic cancer	0.000136	0.000751	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000135	0.00702	CbGpPWpGaD
Gadoxetate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000135	0.000746	CcSEcCtD
Gadoxetate—Rash—Fluorouracil—pancreatic cancer	0.000135	0.000745	CcSEcCtD
Gadoxetate—Dermatitis—Fluorouracil—pancreatic cancer	0.000135	0.000744	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—SLC2A2—pancreatic cancer	0.000134	0.00699	CbGpPWpGaD
Gadoxetate—Decreased appetite—Docetaxel—pancreatic cancer	0.000134	0.000741	CcSEcCtD
Gadoxetate—Headache—Fluorouracil—pancreatic cancer	0.000134	0.00074	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000133	0.000736	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000133	0.000736	CcSEcCtD
Gadoxetate—Fatigue—Docetaxel—pancreatic cancer	0.000133	0.000735	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—pancreatic cancer	0.000133	0.000735	CcSEcCtD
Gadoxetate—Nausea—Irinotecan—pancreatic cancer	0.000133	0.000733	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—pancreatic cancer	0.000133	0.000731	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000132	0.00073	CcSEcCtD
Gadoxetate—Constipation—Docetaxel—pancreatic cancer	0.000132	0.000729	CcSEcCtD
Gadoxetate—Chills—Epirubicin—pancreatic cancer	0.000132	0.000727	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000131	0.00682	CbGpPWpGaD
Gadoxetate—Arrhythmia—Epirubicin—pancreatic cancer	0.000131	0.000723	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—HSPA1A—pancreatic cancer	0.00013	0.00677	CbGpPWpGaD
Gadoxetate—Nausea—Gemcitabine—pancreatic cancer	0.000129	0.000714	CcSEcCtD
Gadoxetate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000127	0.000703	CcSEcCtD
Gadoxetate—Nausea—Fluorouracil—pancreatic cancer	0.000127	0.000702	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000126	0.000697	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000126	0.000695	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—pancreatic cancer	0.000126	0.000695	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—pancreatic cancer	0.000126	0.000695	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—pancreatic cancer	0.000125	0.00069	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—pancreatic cancer	0.000124	0.000682	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—pancreatic cancer	0.000123	0.00068	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000123	0.000677	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—HSPA1A—pancreatic cancer	0.000123	0.00637	CbGpPWpGaD
Gadoxetate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000122	0.000675	CcSEcCtD
Gadoxetate—Abdominal pain—Docetaxel—pancreatic cancer	0.000122	0.000674	CcSEcCtD
Gadoxetate—Body temperature increased—Docetaxel—pancreatic cancer	0.000122	0.000674	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—pancreatic cancer	0.000122	0.000672	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—pancreatic cancer	0.000121	0.000669	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—pancreatic cancer	0.00012	0.000664	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000119	0.000654	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000118	0.00615	CbGpPWpGaD
Gadoxetate—Agitation—Epirubicin—pancreatic cancer	0.000117	0.000648	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—pancreatic cancer	0.000116	0.000643	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000116	0.000639	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—pancreatic cancer	0.000115	0.000636	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—pancreatic cancer	0.000115	0.000633	CcSEcCtD
Gadoxetate—Syncope—Epirubicin—pancreatic cancer	0.000115	0.000632	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—pancreatic cancer	0.000114	0.000631	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000114	0.00592	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000114	0.000628	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—pancreatic cancer	0.000113	0.000623	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—EGF—pancreatic cancer	0.000112	0.00584	CbGpPWpGaD
Gadoxetate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000112	0.00062	CcSEcCtD
Gadoxetate—Cough—Epirubicin—pancreatic cancer	0.000111	0.000615	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—pancreatic cancer	0.000111	0.000615	CcSEcCtD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000111	0.00577	CbGpPWpGaD
Gadoxetate—Asthenia—Docetaxel—pancreatic cancer	0.000111	0.000612	CcSEcCtD
Gadoxetate—Convulsion—Epirubicin—pancreatic cancer	0.000111	0.000611	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00011	0.000605	CcSEcCtD
Gadoxetate—Pruritus—Docetaxel—pancreatic cancer	0.000109	0.000603	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—pancreatic cancer	0.000109	0.0006	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—pancreatic cancer	0.000109	0.000599	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—pancreatic cancer	0.000108	0.000598	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000108	0.000596	CcSEcCtD
Gadoxetate—Discomfort—Epirubicin—pancreatic cancer	0.000107	0.000593	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	0.000107	0.00556	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000107	0.00556	CbGpPWpGaD
Gadoxetate—Malaise—Doxorubicin—pancreatic cancer	0.000107	0.000588	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—pancreatic cancer	0.000106	0.000587	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—pancreatic cancer	0.000106	0.000586	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—pancreatic cancer	0.000106	0.000585	CcSEcCtD
Gadoxetate—Diarrhoea—Docetaxel—pancreatic cancer	0.000106	0.000584	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—pancreatic cancer	0.000104	0.000576	CcSEcCtD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000104	0.00542	CbGpPWpGaD
Gadoxetate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000104	0.000575	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—pancreatic cancer	0.000104	0.000575	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000104	0.000573	CcSEcCtD
Gadoxetate—Infection—Epirubicin—pancreatic cancer	0.000104	0.000572	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—HSPA1A—pancreatic cancer	0.000103	0.00537	CbGpPWpGaD
Gadoxetate—Cough—Doxorubicin—pancreatic cancer	0.000103	0.000569	CcSEcCtD
Gadoxetate—Shock—Epirubicin—pancreatic cancer	0.000103	0.000566	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—pancreatic cancer	0.000102	0.000565	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000102	0.000564	CcSEcCtD
Gadoxetate—Dizziness—Docetaxel—pancreatic cancer	0.000102	0.000564	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—SMAD4—pancreatic cancer	0.000102	0.0053	CbGpPWpGaD
Gadoxetate—Tachycardia—Epirubicin—pancreatic cancer	0.000102	0.000561	CcSEcCtD
Gadoxetate—Skin disorder—Epirubicin—pancreatic cancer	0.000101	0.000559	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000101	0.000556	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—pancreatic cancer	0.000101	0.000555	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—pancreatic cancer	0.0001	0.000553	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	9.99e-05	0.000551	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—pancreatic cancer	9.94e-05	0.000549	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—pancreatic cancer	9.94e-05	0.000548	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—pancreatic cancer	9.84e-05	0.000543	CcSEcCtD
Gadoxetate—Vomiting—Docetaxel—pancreatic cancer	9.83e-05	0.000542	CcSEcCtD
Gadoxetate—Rash—Docetaxel—pancreatic cancer	9.74e-05	0.000538	CcSEcCtD
Gadoxetate—Hypotension—Epirubicin—pancreatic cancer	9.74e-05	0.000538	CcSEcCtD
Gadoxetate—Dermatitis—Docetaxel—pancreatic cancer	9.73e-05	0.000537	CcSEcCtD
Gadoxetate—Headache—Docetaxel—pancreatic cancer	9.68e-05	0.000534	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—pancreatic cancer	9.64e-05	0.000532	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.64e-05	0.000532	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—pancreatic cancer	9.58e-05	0.000529	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—pancreatic cancer	9.49e-05	0.000524	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—pancreatic cancer	9.46e-05	0.000522	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—pancreatic cancer	9.41e-05	0.00052	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—pancreatic cancer	9.37e-05	0.000517	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—pancreatic cancer	9.36e-05	0.000517	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.32e-05	0.000515	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—pancreatic cancer	9.29e-05	0.000513	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—pancreatic cancer	9.19e-05	0.000507	CcSEcCtD
Gadoxetate—Nausea—Docetaxel—pancreatic cancer	9.18e-05	0.000507	CcSEcCtD
Gadoxetate—Decreased appetite—Epirubicin—pancreatic cancer	9.06e-05	0.0005	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—pancreatic cancer	9.01e-05	0.000497	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9e-05	0.000497	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—pancreatic cancer	8.99e-05	0.000496	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—pancreatic cancer	8.91e-05	0.000492	CcSEcCtD
Gadoxetate—Paraesthesia—Doxorubicin—pancreatic cancer	8.66e-05	0.000478	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—pancreatic cancer	8.6e-05	0.000475	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—pancreatic cancer	8.59e-05	0.000474	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.52e-05	0.00047	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—pancreatic cancer	8.38e-05	0.000463	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.33e-05	0.00046	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—pancreatic cancer	8.32e-05	0.000459	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—pancreatic cancer	8.28e-05	0.000457	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—pancreatic cancer	8.25e-05	0.000455	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—pancreatic cancer	8.24e-05	0.000455	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—pancreatic cancer	8.24e-05	0.000455	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—IFNA5—pancreatic cancer	8.07e-05	0.0042	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	7.96e-05	0.00413	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Doxorubicin—pancreatic cancer	7.95e-05	0.000439	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.89e-05	0.000435	CcSEcCtD
Gadoxetate—Hypersensitivity—Epirubicin—pancreatic cancer	7.68e-05	0.000424	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—pancreatic cancer	7.66e-05	0.000423	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—pancreatic cancer	7.62e-05	0.000421	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—pancreatic cancer	7.62e-05	0.000421	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PPP2R5B—pancreatic cancer	7.62e-05	0.00396	CbGpPWpGaD
Gadoxetate—Asthenia—Epirubicin—pancreatic cancer	7.48e-05	0.000413	CcSEcCtD
Gadoxetate—Pruritus—Epirubicin—pancreatic cancer	7.37e-05	0.000407	CcSEcCtD
Gadoxetate—Diarrhoea—Epirubicin—pancreatic cancer	7.13e-05	0.000394	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—pancreatic cancer	7.11e-05	0.000392	CcSEcCtD
Gadoxetate—Asthenia—Doxorubicin—pancreatic cancer	6.92e-05	0.000382	CcSEcCtD
Gadoxetate—Dizziness—Epirubicin—pancreatic cancer	6.89e-05	0.00038	CcSEcCtD
Gadoxetate—Pruritus—Doxorubicin—pancreatic cancer	6.82e-05	0.000377	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—pancreatic cancer	6.8e-05	0.00353	CbGpPWpGaD
Gadoxetate—Vomiting—Epirubicin—pancreatic cancer	6.63e-05	0.000366	CcSEcCtD
Gadoxetate—Diarrhoea—Doxorubicin—pancreatic cancer	6.6e-05	0.000364	CcSEcCtD
Gadoxetate—Rash—Epirubicin—pancreatic cancer	6.57e-05	0.000363	CcSEcCtD
Gadoxetate—Dermatitis—Epirubicin—pancreatic cancer	6.57e-05	0.000362	CcSEcCtD
Gadoxetate—Headache—Epirubicin—pancreatic cancer	6.53e-05	0.00036	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	6.48e-05	0.00337	CbGpPWpGaD
Gadoxetate—Dizziness—Doxorubicin—pancreatic cancer	6.38e-05	0.000352	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—TGFB1—pancreatic cancer	6.24e-05	0.00324	CbGpPWpGaD
Gadoxetate—Nausea—Epirubicin—pancreatic cancer	6.19e-05	0.000342	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—pancreatic cancer	6.13e-05	0.000338	CcSEcCtD
Gadoxetate—Rash—Doxorubicin—pancreatic cancer	6.08e-05	0.000336	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—pancreatic cancer	6.08e-05	0.000335	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—pancreatic cancer	6.04e-05	0.000333	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.02e-05	0.00313	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	5.94e-05	0.00309	CbGpPWpGaD
Gadoxetate—Nausea—Doxorubicin—pancreatic cancer	5.73e-05	0.000316	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.43e-05	0.00282	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.1e-05	0.00265	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	5.04e-05	0.00262	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNNB1—pancreatic cancer	4.99e-05	0.00259	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	4.98e-05	0.00259	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PRSS1—pancreatic cancer	4.94e-05	0.00257	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CD44—pancreatic cancer	4.57e-05	0.00237	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PRSS1—pancreatic cancer	4.46e-05	0.00232	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	4.43e-05	0.0023	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA1—pancreatic cancer	4.42e-05	0.0023	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.3e-05	0.00224	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ARG2—pancreatic cancer	4.28e-05	0.00223	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA2—pancreatic cancer	4.12e-05	0.00214	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFB1—pancreatic cancer	4.1e-05	0.00213	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—pancreatic cancer	4.04e-05	0.0021	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.04e-05	0.0021	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ARG2—pancreatic cancer	3.87e-05	0.00201	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	3.86e-05	0.00201	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB1—pancreatic cancer	3.86e-05	0.002	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TYMP—pancreatic cancer	3.74e-05	0.00195	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TYMP—pancreatic cancer	3.38e-05	0.00176	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	3.32e-05	0.00173	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	3.25e-05	0.00169	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	3.1e-05	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.09e-05	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GLP1R—pancreatic cancer	3.02e-05	0.00157	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	3.02e-05	0.00157	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—DPYD—pancreatic cancer	2.97e-05	0.00154	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLAU—pancreatic cancer	2.92e-05	0.00152	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ARG2—pancreatic cancer	2.88e-05	0.0015	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A2—pancreatic cancer	2.82e-05	0.00146	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.79e-05	0.00145	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.79e-05	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.77e-05	0.00144	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GLP1R—pancreatic cancer	2.72e-05	0.00142	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.69e-05	0.0014	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—DPYD—pancreatic cancer	2.68e-05	0.00139	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CG—pancreatic cancer	2.6e-05	0.00135	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—EGF—pancreatic cancer	2.57e-05	0.00134	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A2—pancreatic cancer	2.54e-05	0.00132	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.52e-05	0.00131	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TYMP—pancreatic cancer	2.52e-05	0.00131	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.45e-05	0.00127	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.43e-05	0.00126	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	2.35e-05	0.00122	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CD—pancreatic cancer	2.28e-05	0.00119	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.21e-05	0.00115	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CD44—pancreatic cancer	2.18e-05	0.00113	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.14e-05	0.00111	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.12e-05	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GCG—pancreatic cancer	2.09e-05	0.00109	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.08e-05	0.00108	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	2.03e-05	0.00105	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—DPYD—pancreatic cancer	2e-05	0.00104	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CB—pancreatic cancer	1.99e-05	0.00103	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CD44—pancreatic cancer	1.97e-05	0.00102	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—STK11—pancreatic cancer	1.97e-05	0.00102	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.93e-05	0.001	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.92e-05	0.001	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.91e-05	0.000993	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	1.89e-05	0.000984	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GCG—pancreatic cancer	1.89e-05	0.000981	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.87e-05	0.000974	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.85e-05	0.00096	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.81e-05	0.00094	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—STK11—pancreatic cancer	1.77e-05	0.000923	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TYMS—pancreatic cancer	1.69e-05	0.00088	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.67e-05	0.000866	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.65e-05	0.000856	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SRC—pancreatic cancer	1.6e-05	0.000829	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—pancreatic cancer	1.55e-05	0.000808	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NRAS—pancreatic cancer	1.54e-05	0.000798	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TYMS—pancreatic cancer	1.53e-05	0.000794	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CD44—pancreatic cancer	1.47e-05	0.000762	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.44e-05	0.000746	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—pancreatic cancer	1.43e-05	0.000741	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.42e-05	0.000739	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GCG—pancreatic cancer	1.41e-05	0.000731	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APOE—pancreatic cancer	1.38e-05	0.000715	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—STK11—pancreatic cancer	1.32e-05	0.000687	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—pancreatic cancer	1.32e-05	0.000687	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.3e-05	0.000677	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CG—pancreatic cancer	1.24e-05	0.000646	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APOE—pancreatic cancer	1.24e-05	0.000645	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.24e-05	0.000645	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	1.21e-05	0.000631	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARG—pancreatic cancer	1.2e-05	0.000623	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.18e-05	0.000611	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—pancreatic cancer	1.17e-05	0.00061	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.14e-05	0.000591	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—pancreatic cancer	1.12e-05	0.000584	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CG—pancreatic cancer	1.12e-05	0.000582	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	1.09e-05	0.000567	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARG—pancreatic cancer	1.08e-05	0.000562	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—pancreatic cancer	9.92e-06	0.000515	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CD—pancreatic cancer	9.85e-06	0.000512	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	9.52e-06	0.000495	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	9.43e-06	0.00049	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APOE—pancreatic cancer	9.25e-06	0.000481	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.75e-06	0.000455	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CB—pancreatic cancer	8.59e-06	0.000446	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—pancreatic cancer	8.51e-06	0.000442	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	8.34e-06	0.000434	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—pancreatic cancer	8.22e-06	0.000427	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARG—pancreatic cancer	8.05e-06	0.000419	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—pancreatic cancer	7.42e-06	0.000386	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	7.34e-06	0.000381	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	6.39e-06	0.000332	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	6.34e-06	0.000329	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	5.8e-06	0.000302	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—pancreatic cancer	5.53e-06	0.000287	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—pancreatic cancer	5.23e-06	0.000272	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—pancreatic cancer	4.74e-06	0.000246	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—pancreatic cancer	4.28e-06	0.000222	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	3.9e-06	0.000203	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—pancreatic cancer	3.18e-06	0.000166	CbGpPWpGaD
